A share price of Exelixis Inc [EXEL] is currently trading at $44.65, up 20.84%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EXEL shares have gain 21.30% over the last week, with a monthly amount glided 24.93%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on February 24, 2025, when Wells Fargo downgraded its rating to a Equal Weight but kept the price target unchanged to $36 for it. Previously, Morgan Stanley upgraded its rating to Overweight on January 27, 2025, and elevated its price target to $40. On January 24, 2025, downgrade downgraded it’s rating to Perform. BMO Capital Markets downgraded its rating to a Market Perform and increased its price target to $40 on December 20, 2024. BofA Securities downgraded its rating to a Neutral and raised its price target to $39 on December 17, 2024. RBC Capital Mkts reiterated a Outperform rating for this stock on October 16, 2024, and upped its price target to $34. In a note dated September 19, 2024, UBS initiated an Neutral rating and provided a target price of $30 on this stock.
Exelixis Inc experienced fluctuations in its stock price throughout the past year between $20.14 and $40.26. Currently, Wall Street analysts expect the stock to reach $42 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $44.65 at the most recent close of the market. An investor can expect a potential drop of -5.94% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Trailing Twelve Months sales for Exelixis Inc [NASDAQ:EXEL] were 2.30B which represents 30.62% growth. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.28%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.24%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.24 and Total Capital is 0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.65 points at the first support level, and at 38.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.47, and for the 2nd resistance point, it is at 48.29.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Exelixis Inc [NASDAQ:EXEL] is 3.50. In addition, the Quick Ratio stands at 3.44 and the Cash Ratio stands at 0.54. Considering the valuation of this stock, the price to sales ratio is 5.30, the price to book ratio is 5.76 and price to earnings (TTM) ratio is 20.26.
Transactions by insiders
Recent insider trading involved PATRICK JOSEPH HALEY, Officer, that happened on May 14 ’25 when 10000.0 shares were purchased. CSO/EVP Disc & Trans Research, Aftab Dana completed a deal on May 01 ’25 to sell 1508.0 shares. Meanwhile, Officer DANA T AFTAB bought 1508.0 shares on May 01 ’25.
